telitacicept: Clinical Trials

8 trials of telitacicept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Unknown 3, Not yet recruiting 2, Recruiting 2, Active not recruiting 1

Follow telitacicept: new trials by email Literature Review of telitacicept trials Research Report on telitacicept

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Telitacicept for the Treatment of Refractory RA
Telitacicept - Rheumatoid Arthritis (RA)
Phase 4Not yet recruitingChinese SLE Treatment And Research Group302025-06-102025-06-06
Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
Telitacicept - Myasthenia Gravis, Autoimmune Diseases
Phase 4Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University302024-12-012024-12-09
Immune Cell Subsets in SLE Patients Treated with Telitacicept
Telitacicept 160mg - Systemic Lupus Erythematosus (SLE)
Phase 4Active not recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine502024-10-112024-11-07
The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
Telitacicept - Systemic Sclerosis
Phase 4UnknownPeking University Third Hospital202024-06-082024-08-09
Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)
Telitacicept, Placebo of Telitacicept - ANCA Associated Vasculitis
Phase 4RecruitingChinese SLE Treatment And Research Group402023-06-292023-07-27
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Azathioprine, Telitacicept - ANCA-associated Vasculitis, Maintenance Therapy
Phase 4RecruitingChinese SLE Treatment And Research Group402023-03-092023-07-28
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
Telitacicept, Hydroxychloroquine, Prednisone - Systemic Lupus Erythematosus
Phase 4UnknownFen Li302022-12-312024-01-17
Efficacy and Safety of Telitacicept in Early SLE
Telitacicept, Standard of Care - Lupus Erythematosus, Systemic
Phase 4UnknownPeking Union Medical College Hospital1802022-09-012023-06-12

Conditions studied

Lupus Erythematosus, Systemic (3)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Arthritis, Rheumatoid (1)  ·  Autoimmune Diseases (1)  ·  Myasthenia Gravis (1)  ·  Scleroderma, Systemic (1)

Sponsors

Chinese SLE Treatment And Research Group (3)  ·  Fen Li (1)  ·  First Affiliated Hospital of Wenzhou Medical University (1)  ·  Peking Union Medical College Hospital (1)  ·  Peking University Third Hospital (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (7)

Top investigators

Fen Li, doctor (1)  ·  JIng Li, M.D. (1)  ·  Jing Li, MD (1)  ·  Xiaomei Leng (1)  ·  Xinping Tian, MD (1)